GO:0006658 | phosphatidylserine metabolic process | 6.45% (6/93) | 9.92 | 0.0 | 0.0 |
GO:0106245 | L-serine-phosphatidylethanolamine phosphatidyltransferase activity | 6.45% (6/93) | 9.96 | 0.0 | 0.0 |
GO:0006659 | phosphatidylserine biosynthetic process | 6.45% (6/93) | 9.96 | 0.0 | 0.0 |
GO:0042398 | cellular modified amino acid biosynthetic process | 6.45% (6/93) | 7.21 | 0.0 | 0.0 |
GO:0016780 | phosphotransferase activity, for other substituted phosphate groups | 6.45% (6/93) | 6.82 | 0.0 | 0.0 |
GO:0006575 | cellular modified amino acid metabolic process | 6.45% (6/93) | 6.25 | 0.0 | 0.0 |
GO:0046474 | glycerophospholipid biosynthetic process | 6.45% (6/93) | 4.98 | 0.0 | 3e-06 |
GO:0045017 | glycerolipid biosynthetic process | 6.45% (6/93) | 4.76 | 0.0 | 6e-06 |
GO:0008654 | phospholipid biosynthetic process | 6.45% (6/93) | 4.6 | 0.0 | 1e-05 |
GO:0006650 | glycerophospholipid metabolic process | 6.45% (6/93) | 4.41 | 0.0 | 2e-05 |
GO:0046486 | glycerolipid metabolic process | 6.45% (6/93) | 4.2 | 1e-06 | 4.2e-05 |
GO:0016740 | transferase activity | 23.66% (22/93) | 1.61 | 2e-06 | 6.9e-05 |
GO:0003830 | beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | 2.15% (2/93) | 9.75 | 2e-06 | 7.6e-05 |
GO:0006044 | N-acetylglucosamine metabolic process | 2.15% (2/93) | 9.75 | 2e-06 | 7.6e-05 |
GO:0006644 | phospholipid metabolic process | 6.45% (6/93) | 3.81 | 5e-06 | 0.000148 |
GO:1901564 | organonitrogen compound metabolic process | 23.66% (22/93) | 1.51 | 6e-06 | 0.000155 |
GO:0090407 | organophosphate biosynthetic process | 6.45% (6/93) | 3.4 | 2.5e-05 | 0.000623 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 15.05% (14/93) | 1.84 | 3.6e-05 | 0.000848 |
GO:0006796 | phosphate-containing compound metabolic process | 15.05% (14/93) | 1.75 | 6.9e-05 | 0.001555 |
GO:0006793 | phosphorus metabolic process | 15.05% (14/93) | 1.74 | 7.3e-05 | 0.00157 |
GO:0008610 | lipid biosynthetic process | 6.45% (6/93) | 2.93 | 0.000148 | 0.003025 |
GO:0044255 | cellular lipid metabolic process | 7.53% (7/93) | 2.57 | 0.000193 | 0.003764 |
GO:0044238 | primary metabolic process | 29.03% (27/93) | 1.01 | 0.000207 | 0.00386 |
GO:0019538 | protein metabolic process | 17.2% (16/93) | 1.41 | 0.00031 | 0.005543 |
GO:1901071 | glucosamine-containing compound metabolic process | 2.15% (2/93) | 6.27 | 0.000327 | 0.005609 |
GO:0140103 | catalytic activity, acting on a glycoprotein | 2.15% (2/93) | 6.17 | 0.000371 | 0.005891 |
GO:0008353 | RNA polymerase II CTD heptapeptide repeat kinase activity | 2.15% (2/93) | 6.2 | 0.000359 | 0.005916 |
GO:0034243 | regulation of transcription elongation by RNA polymerase II | 2.15% (2/93) | 5.84 | 0.000584 | 0.007826 |
GO:0006807 | nitrogen compound metabolic process | 24.73% (23/93) | 1.04 | 0.000566 | 0.007828 |
GO:0071704 | organic substance metabolic process | 29.03% (27/93) | 0.93 | 0.000553 | 0.007905 |
GO:0032968 | positive regulation of transcription elongation by RNA polymerase II | 2.15% (2/93) | 5.9 | 0.000543 | 0.008038 |
GO:0008375 | acetylglucosaminyltransferase activity | 2.15% (2/93) | 5.9 | 0.000543 | 0.008038 |
GO:0140096 | catalytic activity, acting on a protein | 15.05% (14/93) | 1.42 | 0.000717 | 0.008542 |
GO:0019637 | organophosphate metabolic process | 6.45% (6/93) | 2.5 | 0.000706 | 0.008656 |
GO:0036211 | protein modification process | 13.98% (13/93) | 1.49 | 0.000693 | 0.008744 |
GO:0005794 | Golgi apparatus | 4.3% (4/93) | 3.35 | 0.000677 | 0.008806 |
GO:0070816 | obsolete phosphorylation of RNA polymerase II C-terminal domain | 2.15% (2/93) | 5.64 | 0.000771 | 0.008944 |
GO:0006040 | amino sugar metabolic process | 2.15% (2/93) | 5.53 | 0.0009 | 0.010159 |
GO:0035102 | PRC1 complex | 1.08% (1/93) | 10.07 | 0.000928 | 0.01021 |
GO:0140994 | RNA polymerase II CTD heptapeptide repeat modifying activity | 2.15% (2/93) | 5.47 | 0.000971 | 0.010414 |
GO:0006629 | lipid metabolic process | 7.53% (7/93) | 2.15 | 0.001058 | 0.011073 |
GO:1901566 | organonitrogen compound biosynthetic process | 6.45% (6/93) | 2.38 | 0.001113 | 0.011367 |
GO:0000152 | nuclear ubiquitin ligase complex | 2.15% (2/93) | 5.33 | 0.001178 | 0.011489 |
GO:0008152 | metabolic process | 29.03% (27/93) | 0.86 | 0.00117 | 0.011676 |
GO:0043413 | macromolecule glycosylation | 3.23% (3/93) | 3.84 | 0.001263 | 0.011776 |
GO:0006486 | protein glycosylation | 3.23% (3/93) | 3.84 | 0.001263 | 0.011776 |
GO:0032786 | positive regulation of DNA-templated transcription, elongation | 2.15% (2/93) | 5.23 | 0.001358 | 0.012397 |
GO:0070085 | glycosylation | 3.23% (3/93) | 3.75 | 0.001517 | 0.013561 |
GO:0032784 | regulation of DNA-templated transcription elongation | 2.15% (2/93) | 4.94 | 0.002018 | 0.017663 |
GO:0015297 | antiporter activity | 3.23% (3/93) | 3.59 | 0.002096 | 0.017984 |
GO:0043412 | macromolecule modification | 13.98% (13/93) | 1.31 | 0.002161 | 0.018179 |
GO:0008150 | biological_process | 41.94% (39/93) | 0.59 | 0.002371 | 0.019195 |
GO:0065007 | biological regulation | 13.98% (13/93) | 1.3 | 0.002329 | 0.019212 |
GO:0035098 | ESC/E(Z) complex | 1.08% (1/93) | 8.66 | 0.002473 | 0.019649 |
GO:0006487 | protein N-linked glycosylation | 2.15% (2/93) | 4.73 | 0.00267 | 0.020828 |
GO:0000307 | cyclin-dependent protein kinase holoenzyme complex | 2.15% (2/93) | 4.6 | 0.003184 | 0.024394 |
GO:0003824 | catalytic activity | 30.11% (28/93) | 0.73 | 0.003321 | 0.024997 |
GO:0050789 | regulation of biological process | 12.9% (12/93) | 1.28 | 0.003712 | 0.027455 |
GO:0015291 | secondary active transmembrane transporter activity | 3.23% (3/93) | 3.23 | 0.004222 | 0.0307 |
GO:0043085 | positive regulation of catalytic activity | 2.15% (2/93) | 4.37 | 0.004353 | 0.031124 |
GO:0015786 | UDP-glucose transmembrane transport | 1.08% (1/93) | 7.8 | 0.004478 | 0.031496 |
GO:0044093 | positive regulation of molecular function | 2.15% (2/93) | 4.27 | 0.004994 | 0.034553 |
GO:0016757 | glycosyltransferase activity | 5.38% (5/93) | 2.17 | 0.005239 | 0.035678 |
GO:0043231 | intracellular membrane-bounded organelle | 15.05% (14/93) | 1.1 | 0.00534 | 0.035797 |
GO:0006897 | endocytosis | 2.15% (2/93) | 4.16 | 0.005767 | 0.037485 |
GO:0043227 | membrane-bounded organelle | 15.05% (14/93) | 1.09 | 0.005699 | 0.037613 |
GO:0010105 | negative regulation of ethylene-activated signaling pathway | 1.08% (1/93) | 7.2 | 0.006787 | 0.039347 |
GO:0070298 | negative regulation of phosphorelay signal transduction system | 1.08% (1/93) | 7.2 | 0.006787 | 0.039347 |
GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase | 1.08% (1/93) | 7.2 | 0.006787 | 0.039347 |
GO:1902554 | serine/threonine protein kinase complex | 2.15% (2/93) | 4.02 | 0.006905 | 0.039497 |
GO:1902911 | protein kinase complex | 2.15% (2/93) | 3.99 | 0.007191 | 0.039553 |
GO:0016758 | hexosyltransferase activity | 4.3% (4/93) | 2.47 | 0.006199 | 0.039691 |
GO:0031519 | PcG protein complex | 1.08% (1/93) | 7.3 | 0.006326 | 0.039908 |
GO:0050794 | regulation of cellular process | 11.83% (11/93) | 1.23 | 0.007175 | 0.039974 |
GO:0016192 | vesicle-mediated transport | 4.3% (4/93) | 2.39 | 0.007369 | 0.040014 |
GO:0044249 | cellular biosynthetic process | 8.6% (8/93) | 1.51 | 0.007144 | 0.040328 |
GO:0023051 | regulation of signaling | 2.15% (2/93) | 4.04 | 0.006723 | 0.04062 |
GO:0010646 | regulation of cell communication | 2.15% (2/93) | 4.04 | 0.006706 | 0.041099 |
GO:0009966 | regulation of signal transduction | 2.15% (2/93) | 4.05 | 0.006624 | 0.041184 |
GO:0006468 | protein phosphorylation | 8.6% (8/93) | 1.49 | 0.00795 | 0.042631 |
GO:0097027 | ubiquitin-protein transferase activator activity | 1.08% (1/93) | 6.53 | 0.010776 | 0.048663 |
GO:1905786 | positive regulation of anaphase-promoting complex-dependent catabolic process | 1.08% (1/93) | 6.53 | 0.010776 | 0.048663 |
GO:1903322 | positive regulation of protein modification by small protein conjugation or removal | 1.08% (1/93) | 6.53 | 0.010776 | 0.048663 |
GO:0031398 | positive regulation of protein ubiquitination | 1.08% (1/93) | 6.53 | 0.010776 | 0.048663 |
GO:1904668 | positive regulation of ubiquitin protein ligase activity | 1.08% (1/93) | 6.53 | 0.010776 | 0.048663 |
GO:1905784 | regulation of anaphase-promoting complex-dependent catabolic process | 1.08% (1/93) | 6.53 | 0.010776 | 0.048663 |
GO:1990757 | ubiquitin ligase activator activity | 1.08% (1/93) | 6.53 | 0.010776 | 0.048663 |
GO:0051443 | positive regulation of ubiquitin-protein transferase activity | 1.08% (1/93) | 6.53 | 0.010776 | 0.048663 |
GO:0043170 | macromolecule metabolic process | 19.35% (18/93) | 0.83 | 0.010959 | 0.048971 |
GO:0070297 | regulation of phosphorelay signal transduction system | 1.08% (1/93) | 6.68 | 0.009704 | 0.048975 |
GO:0010104 | regulation of ethylene-activated signaling pathway | 1.08% (1/93) | 6.68 | 0.009704 | 0.048975 |
GO:1990234 | transferase complex | 4.3% (4/93) | 2.21 | 0.011245 | 0.049225 |
GO:0010997 | anaphase-promoting complex binding | 1.08% (1/93) | 6.47 | 0.011235 | 0.049691 |
GO:1901576 | organic substance biosynthetic process | 8.6% (8/93) | 1.39 | 0.011482 | 0.049758 |
GO:0098657 | import into cell | 2.15% (2/93) | 3.78 | 0.009536 | 0.049889 |